Quit4Baby: Reaching Pregnant Smokers With Health Information Via Text
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 99
- 试验地点
- 2
- 主要终点
- Smoking Abstinence
研究概览
简要总结
Despite the great health benefits associated with smoking cessation in pregnancy to both mother and baby, few studies to date have examined the applications of text messaging or other communication technologies for smoking cessation in this population. This project is the first step in developing a new dissemination strategy for reaching pregnant smokers. This research will explore how a state-of -the-art, interactive and intensive, text messaging program, SmokefreeMoms Text, can promote smoking cessation in pregnant smokers. This program may have the potential to reach pregnant smokers who are not currently being reached with traditional smoking cessation services. The study Aims are: 1) to elicit qualitative feedback from pregnant smokers and recent quitters (in the past month) about the concept of SmokefreeMoms, the proposed message protocols in SmokefreeMoms, and the proposed messages in SmokefreeMoms (Phase 1); 2) To develop and pilot test a prototype of SmokefreeMoms which is consistent with Clinical Practice Guidelines (Phase 2), and 3) To conduct a formative evaluation of SmokefreeMoms 1.0 with pregnant smokers and recent quitters (Phase 3). 4) To measure the likelihood that pregnant women who smoke cigarettes will join an SMS program by responding to different types of recruitment messages.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 13 Years 至 44 Years(Child, Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •smoke or quit in the past 2 weeks,
- •has a data plan or an unlimited text messaging plan on her cell in order to avoid charges for texts,
- •an English speaker.
排除标准
- •not pregnant
- •not currently smoking (or within past 2 weeks)
- •not able to receive text messages
- •not an English speaker
结局指标
主要结局
Smoking Abstinence
时间窗: 3 months
7-day point prevalence abstinence measured by Self-Report and Confirmed with Saliva Cotinine
次要结局
未报告次要终点
研究者
Lorien Abroms
Associate Professor
George Washington University
